We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
3226
Scholar Rock
SRRK
$6.31B
-29,405
Closed -$379K
STIM icon
3227
Neuronetics
STIM
$157M
-19,248
Closed -$58K
STTK icon
3228
Shattuck Labs
STTK
$684M
-26,270
Closed -$112K
STXS icon
3229
Stereotaxis
STXS
$135M
-41,897
Closed -$156K
SYRE icon
3230
Spyre Therapeutics
SYRE
$9.12B
-1,957
Closed -$113K
TCRT icon
3231
Alaunos Therapeutics
TCRT
$4.86M
-1,460
Closed -$143K
TISI icon
3232
Team
TISI
$77.8M
-3,655
Closed -$81K
TNXP icon
3233
Tonix Pharmaceuticals
TNXP
$186M
-1
Closed -$86K
TOON icon
3234
Kartoon Studios
TOON
$35.1M
-31,368
Closed -$320K
TSAT icon
3235
Telesat
TSAT
$823M
-10,429
Closed -$172K
TSHA icon
3236
Taysha Gene Therapies
TSHA
$1.82B
-22,389
Closed -$146K
TXMD icon
3237
TherapeuticsMD
TXMD
$24.2M
-6,251
Closed -$119K
UAVS icon
3238
AgEagle Aerial Systems
UAVS
$42.1M
-67
Closed -$80K
URGN icon
3239
UroGen Pharma
URGN
$2.22B
-23,152
Closed -$202K
VATE icon
3240
INNOVATE Corp
VATE
$101M
-6,284
Closed -$232K
VHC icon
3241
VirnetX Holding Corp
VHC
$67M
-4,277
Closed -$139K
VKTX icon
3242
Viking Therapeutics
VKTX
$3.88B
-92,483
Closed -$277K
VMD icon
3243
Viemed Healthcare
VMD
$363M
-42,419
Closed -$211K
VOR icon
3244
Vor Biopharma
VOR
$1.28B
-817
Closed -$99K
VRA icon
3245
Vera Bradley
VRA
$96.1M
-72,976
Closed -$560K
VRCA icon
3246
Verrica Pharmaceuticals
VRCA
$92.1M
-1,277
Closed -$104K
VRM icon
3247
Vroom Inc
VRM
$48.3M
-1,187
Closed -$253K
VSTM icon
3248
Verastem
VSTM
$519M
-13,953
Closed -$236K
WVE icon
3249
Wave Life Sciences
WVE
$1.19B
-40,249
Closed -$80K
XBIT icon
3250
XBiotech
XBIT
$69.5M
-18,748
Closed -$162K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.